Analyze Diet
The Journal of clinical endocrinology and metabolism1969; 29(2); 225-230; doi: 10.1210/jcem-29-2-225

Corpus luteum function in early pregnancy.

Abstract: No abstract available
Publication Date: 1969-02-01 PubMed ID: 5764544DOI: 10.1210/jcem-29-2-225Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Cite This Article

APA
Yoshimi T, Strott CA, Marshall JR, Lipsett MB. (1969). Corpus luteum function in early pregnancy. J Clin Endocrinol Metab, 29(2), 225-230. https://doi.org/10.1210/jcem-29-2-225

Publication

ISSN: 0021-972X
NlmUniqueID: 0375362
Country: United States
Language: English
Volume: 29
Issue: 2
Pages: 225-230

Researcher Affiliations

Yoshimi, T
    Strott, C A
      Marshall, J R
        Lipsett, M B

          MeSH Terms

          • Abortion, Spontaneous / blood
          • Chorionic Gonadotropin / blood
          • Chorionic Gonadotropin / pharmacology
          • Corpus Luteum / metabolism
          • Female
          • Gonadotropins, Equine / pharmacology
          • Humans
          • Hydroxyprogesterones / blood
          • Ovulation
          • Placenta / metabolism
          • Pregnancy
          • Progesterone / biosynthesis
          • Progesterone / blood

          Citations

          This article has been cited 16 times.
          1. Adriaansen BPH, Schröder MAM, Span PN, Sweep FCGJ, van Herwaarden AE, Claahsen-van der Grinten HL. Challenges in treatment of patients with non-classic congenital adrenal hyperplasia.. Front Endocrinol (Lausanne) 2022;13:1064024.
            doi: 10.3389/fendo.2022.1064024pubmed: 36578966google scholar: lookup
          2. Ku CW, Zhang X, Zhang VR, Allen JC, Tan NS, Østbye T, Tan TC. Gestational age-specific normative values and determinants of serum progesterone through the first trimester of pregnancy.. Sci Rep 2021 Feb 18;11(1):4161.
            doi: 10.1038/s41598-021-83805-wpubmed: 33603122google scholar: lookup
          3. Achong N, McIntyre HD, Callaway L. Factors determining insulin requirements in women with type 1 diabetes mellitus during pregnancy: a review.. Obstet Med 2014 Jun;7(2):52-9.
            doi: 10.1177/1753495X13516442pubmed: 27512424google scholar: lookup
          4. Koistinen H, Hautala L, Koli K, Stenman UH. Absence of TGF-β Receptor Activation by Highly Purified hCG Preparations.. Mol Endocrinol 2015 Dec;29(12):1787-91.
            doi: 10.1210/me.2015-1187pubmed: 26495869google scholar: lookup
          5. Mistry HD, Eisele N, Escher G, Dick B, Surbek D, Delles C, Currie G, Schlembach D, Mohaupt MG, Gennari-Moser C. Gestation-specific reference intervals for comprehensive spot urinary steroid hormone metabolite analysis in normal singleton pregnancy and 6 weeks postpartum.. Reprod Biol Endocrinol 2015 Sep 4;13:101.
            doi: 10.1186/s12958-015-0100-6pubmed: 26337185google scholar: lookup
          6. Chen T, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H, Kaaks R, Koskela P, Grankvist K, Hallmans G, Pukkala E, Zeleniuch-Jacquotte A, Toniolo P, Lehtinen M, Lukanova A. Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer.. Cancer Epidemiol Biomarkers Prev 2011 Feb;20(2):324-36.
            doi: 10.1158/1055-9965.EPI-10-0857pubmed: 21177423google scholar: lookup
          7. Gillott DJ, Iles RK, Chard T. The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines.. Br J Cancer 1996 Feb;73(3):323-6.
            doi: 10.1038/bjc.1996.56pubmed: 8562337google scholar: lookup
          8. Russo J, Russo IH. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence.. Am J Pathol 1980 Aug;100(2):497-512.
            pubmed: 6773421
          9. Singer A, Walker P, Tay SK, Dyson J. Impact of introduction of colposcopy to a district general hospital.. Br Med J (Clin Res Ed) 1984 Oct 20;289(6451):1049-51.
            doi: 10.1136/bmj.289.6451.1049pubmed: 6435769google scholar: lookup
          10. van der Spuy ZM, Jacobs HS. Management of endocrine disorders in pregnancy. Part II. Pituitary, ovarian and adrenal disease.. Postgrad Med J 1984 May;60(703):312-20.
            doi: 10.1136/pgmj.60.703.312pubmed: 6330715google scholar: lookup
          11. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis.. Breast Cancer Res Treat 1982;2(1):5-73.
            doi: 10.1007/BF01805718pubmed: 6216933google scholar: lookup
          12. Macnaughton MC, Coutts JR, Browning MC. Steroid excretion in molar pregnancy and early hormone-induced pregnancy.. Proc R Soc Med 1970 Nov;63(11 Part 1):1087-8.
            pubmed: 5484920
          13. Murphy BE. Competitive protein-binding radioassays in the diagnosis of endocrine disorders.. Can Med Assoc J 1972 Feb 19;106(4):360-4.
            pubmed: 5061131
          14. Distler W, Hüsgen P, Kozlowski P, Terinde R. The value of ovarian and placental steroid determinations in abnormal early pregnancy.. Arch Gynecol 1985;236(3):153-60.
            doi: 10.1007/BF02133958pubmed: 4015191google scholar: lookup
          15. Hassiakos D, Mantzavinos T, Kalomiris K, Zourlas PA. Comparison of maternal serum estradiol and progesterone levels in pregnancies after induced and spontaneous ovulation.. Arch Gynecol Obstet 1991;248(3):145-50.
            doi: 10.1007/BF02390092pubmed: 2018410google scholar: lookup
          16. Schmidt-Gollwitzer M, Leyendecker G. The effect of prostaglandin f2alpha on endocrine parameters in early pregnancy.. Arch Gynakol 1977 Mar 31;222(2):149-57.
            doi: 10.1007/BF00667198pubmed: 577127google scholar: lookup